{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:45:20Z","timestamp":1793835920563,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpba.2025.117056","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T11:13:58Z","timestamp":1751886838000},"page":"117056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A new STAT3-based potency assay for human G-CSF analog therapeutics"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5756-7727","authenticated-orcid":false,"given":"Tao","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Angart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6468-6617","authenticated-orcid":false,"given":"David M.","family":"Frucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117056_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cyto.2008.03.002","article-title":"Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis","volume":"42","author":"Panopoulos","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.jpba.2025.117056_bib2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2741\/2103","article-title":"Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders","volume":"12","author":"Touw","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jpba.2025.117056_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood.V88.3.761.bloodjournal883761","article-title":"Molecular analysis of the granulocyte colony-stimulating factor receptor","volume":"88","author":"Avalos","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2025.117056_bib4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1080\/16078454.2021.1965725","article-title":"New insight into the mechanism of granulocyte colony-stimulating factor (G-CSF) that induces the mobilization of neutrophils","volume":"26","author":"Theyab","year":"2021","journal-title":"Hematology"},{"key":"10.1016\/j.jpba.2025.117056_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.932608","article-title":"A review of granulocyte colony-stimulating factor receptor signaling and regulation with implications for cancer","volume":"12","author":"Park","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpba.2025.117056_bib6","first-page":"7067","article-title":"Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)","volume":"30","author":"Link","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpba.2025.117056_bib7","series-title":"FDA-Approved Drugs","author":"Drugs@FDA","year":"2025"},{"key":"10.1016\/j.jpba.2025.117056_bib8","doi-asserted-by":"crossref","first-page":"1026377","DOI":"10.3389\/fonc.2022.1026377","article-title":"New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy","volume":"12","author":"Theyab","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpba.2025.117056_bib9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s40265-023-01911-7","article-title":"Efbemalenograstim alfa: first approval","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2025.117056_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11051434","article-title":"FDA approvals of biologics in 2022","volume":"11","author":"Martins","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpba.2025.117056_bib11","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/s41598-020-59346-z","article-title":"The ELISA detectability and potency of pegfilgrastim decrease in physiological conditions: key roles for aggregation and individual variability","volume":"10","author":"Xie","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2025.117056_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biologicals.2017.06.001","article-title":"A demonstration of analytical similarity comparing a proposed biosimilar pegfilgrastim and reference pegfilgrastim","volume":"48","author":"Brokx","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.jpba.2025.117056_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11095-018-2491-5","article-title":"Quality comparison of biosimilar and copy filgrastim products with the innovator product","volume":"35","author":"Halim","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2025.117056_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/11585100-000000000-00000","article-title":"Physicochemical and biologic comparability of a biosimilar granulocyte colony-stimulating factor with its reference product","volume":"24","author":"Sorgel","year":"2010","journal-title":"BioDrugs"},{"key":"10.1016\/j.jpba.2025.117056_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309480","article-title":"Demonstration of physicochemical and functional similarity between Stimufend (pegfilgrastim-fpgk) and Neulasta (pegfilgrastim): a comparative analytical assessment","volume":"19","author":"Sykes","year":"2024","journal-title":"PLOS One"},{"key":"10.1016\/j.jpba.2025.117056_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jim.2014.10.005","article-title":"s. participants of the, Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF): report of an international collaborative study","volume":"416","author":"Wadhwa","year":"2015","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jpba.2025.117056_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jim.2011.02.005","article-title":"Participants of the Collaborative, The 2nd International Standard for human granulocyte colony stimulating factor","volume":"367","author":"Wadhwa","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jpba.2025.117056_bib18","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1073\/pnas.87.22.8702","article-title":"Three different mRNAs encoding human granulocyte colony-stimulating factor receptor","volume":"87","author":"Fukunaga","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpba.2025.117056_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/44394","article-title":"Atomic structure of the GCSF-receptor complex showing a new cytokine-receptor recognition scheme","volume":"401","author":"Aritomi","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2025.117056_bib20","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1073\/pnas.0511264103","article-title":"Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex","volume":"103","author":"Tamada","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpba.2025.117056_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1074-7613(01)00101-7","article-title":"STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation","volume":"14","author":"McLemore","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jpba.2025.117056_bib22","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood-2006-02-003012","article-title":"STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils","volume":"108","author":"Panopoulos","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2025.117056_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2007.04.017","article-title":"Formulation of neulasta (pegfilgrastim)","volume":"60","author":"Piedmonte","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2025.117056_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1677\/joe.0.1650301","article-title":"Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone","volume":"165","author":"Von Laue","year":"2000","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jpba.2025.117056_bib25","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1074\/jbc.273.2.1058","article-title":"Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Selective activation of Jak2, Stat3, and Stat5b","volume":"273","author":"Al-Shami","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2025.117056_bib26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1248\/bpb.20.943","article-title":"Bioassay of human granulocyte colony-stimulating factor using human promyelocytic HL-60 cells","volume":"20","author":"Yamaguchi","year":"1997","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2025.117056_bib27","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood.V75.6.1228.1228","article-title":"Quantitative in vivo assay of human granulocyte colony-stimulating factor using cyclophosphamide-induced neutropenic mice","volume":"75","author":"Hattori","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2025.117056_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0003-2697(91)90291-Z","article-title":"Mutant protein of recombinant human granulocyte colony-stimulating factor for receptor binding assay","volume":"195","author":"Watanabe","year":"1991","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2025.117056_bib29","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1073\/pnas.81.12.3765","article-title":"Binding of the differentiation-inducer, granulocyte-colony-stimulating factor, to responsive but not unresponsive leukemic cell lines","volume":"81","author":"Nicola","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpba.2025.117056_bib30","first-page":"116","article-title":"A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders","volume":"17","author":"Shirafuji","year":"1989","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jpba.2025.117056_bib31","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4049\/jimmunol.145.3.860","article-title":"Differentiation of the IL-3-dependent NFS-60 cell line and adaption to growth in macrophage colony-stimulating factor","volume":"145","author":"Nakoinz","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpba.2025.117056_bib32","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V77.9.2031.2031","article-title":"Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation","volume":"77","author":"Asou","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2025.117056_bib33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/13880209.2014.943248","article-title":"A sensitive WST-8-based bioassay for PEGylated granulocyte colony stimulating factor using the NFS-60 cell line","volume":"53","author":"Tiwari","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jpba.2025.117056_bib34","series-title":"Filgrastim Concentrationed Solution. Monograph 2206., European Pharmacopoeia Online. 8.8.European Directorate for the Quality ofMedicines & HealthCare (EDQM)","first-page":"4142","author":"Pharmacopoeia","year":"2016"},{"key":"10.1016\/j.jpba.2025.117056_bib35","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood-2009-12-259630","article-title":"STAT3 controls myeloid progenitor growth during emergency granulopoiesis","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525003978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525003978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T11:33:03Z","timestamp":1755084783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525003978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"alternative-id":["S0731708525003978"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117056","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new STAT3-based potency assay for human G-CSF analog therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117056"}}